Several high-profile research organizations, including the National Institutes of Health, have contributed a number of personalized medicine-focused biomarker- and diagnostics-related patents to a new intellectual property licensing "supermarket" called Librassay.
NIH, Research Groups Submit Dx, Biomarker IP to 'Patent Supermarket' for Non-Exclusive Licensing
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Browse our free articlesYou can still register for access to our free content.